The world of clinical development is both complex and dynamic, which presents both research and development challenges for the pharmaceutical and biotech industry. ICON has a global network of specially designed laboratories dedicated to drug development solutions that meet those challenges.

  • 580+

    Bioanalysis experts across the world
  • 1500*

    Validated assays
  • 6680*

    Studies supported

* last 5 years

We apply integrated medical, scientific and operational excellence that’s essential for reaching decision milestones on-time and with the highest quality and regulatory insights.

We offer the highest quality services for pharmacokinetic, immunogenicity, biomarker, and CMC analysis, utilising a wide range of platforms for small molecules, large molecules, and cell-based entities.

Our three GLP, GCP and GMP compliant laboratories are strategically co-located with ICON’s early phase clinical research units to foster innovative, cross-functional team collaboration and to facilitate the rapid analyses of time-critical samples, and support fast dose escalations that are so crucial in today’s adaptive trials.

Find out more about the ICON laboratory services.